Stem Cell Therapy in Myocardial Infarction: Still Therapeutic Hope?
Romanian Journal of Cardiology · 2022
DOI: 10.2478/rjc-2022-0027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Cardiology, 2022. Verfasst von Alexandru Florinel Oancea und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocardial infarction is still a therapeutic rollercoaster challenge because, despite revolutionary treatments in its management, heart failure is still a consequence. Stem cell therapy might be a turning point in treating myocardial infarction patients for regaining what is lost—that is, myocardial tissue. This paper reviews the latest evidence for using stem cell therapy in the treatment of myocardial infarction, the results of this possible therapy regarding regaining cardiomyocytes, and the extent to which therapy with stem cells can be used in the future for the management of acute coronary syndromes.
Zitieren
APA
Oancea, A. F., Chipăilă, E. D., Iov, E. D., Morariu, P., Tănase, D. M., & Floria, M. (2022). Stem Cell Therapy in Myocardial Infarction: Still Therapeutic Hope?. Romanian Journal of Cardiology. https://doi.org/10.2478/rjc-2022-0027
Vancouver
Oancea AF, Chipăilă ED, Iov ED, Morariu P, Tănase DM, Floria M. Stem Cell Therapy in Myocardial Infarction: Still Therapeutic Hope?. Romanian Journal of Cardiology. 2022. doi:10.2478/rjc-2022-0027
BibTeX
@article{Oancea2022,
author = {Oancea, Alexandru Florinel and Chipăilă, Elena Diana and Iov, Elena Diana and Morariu, Paula and Tănase, Daniela Maria and Floria, Mariana},
title = {Stem Cell Therapy in Myocardial Infarction: Still Therapeutic Hope?},
journal = {Romanian Journal of Cardiology},
year = {2022},
doi = {10.2478/rjc-2022-0027}
}
EUVIMED